Selvita S.A. (WSE:SLV)
37.10
+0.40 (1.09%)
Oct 24, 2025, 5:00 PM CET
Selvita Revenue
Selvita had revenue of 95.03M PLN in the quarter ending June 30, 2025, with 17.44% growth. This brings the company's revenue in the last twelve months to 373.90M, up 13.64% year-over-year. In the year 2024, Selvita had annual revenue of 345.76M, down -1.73%.
Revenue (ttm)
373.90M
Revenue Growth
+13.64%
P/S Ratio
1.82
Revenue / Employee
385.86K
Employees
969
Market Cap
680.99M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 345.76M | -6.09M | -1.73% |
| Dec 31, 2023 | 351.85M | -12.70M | -3.48% |
| Dec 31, 2022 | 364.55M | 48.83M | 15.47% |
| Dec 31, 2021 | 315.73M | 173.80M | 122.46% |
| Dec 31, 2020 | 141.93M | 88.32M | 164.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.04B |
| Diagnostyka | 2.17B |
| Centrum Medyczne ENEL-MED | 789.78M |
| Synektik Spólka Akcyjna | 623.20M |
| Mercator Medical | 579.83M |
| Voxel | 560.38M |
| BIOTON | 265.14M |
| Celon Pharma | 206.22M |